Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Riverstone HoldingsSGX:AP4 -1.14%65 ROC (Joel Greenblatt) % is 29.43% as of Dec. 2025, which is 9% below its 10-year median of 32.47. GuruFocus rates SGX:AP4 with a GF Score™ of 65/100 and a GF Value™ of S$0.87 (Fairly Valued). The stock has 5 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Riverstone Holdings ranks better than 78.61% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Riverstone Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 29.43%.
The historical rank and industry rank for Riverstone Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:
SGX:AP4'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.19 Med: 32.47 Max: 231.1
Current: 28.65
During the past 13 years, Riverstone Holdings's highest ROC (Joel Greenblatt) % was 231.10%. The lowest was 24.19%. And the median was 32.47%.
SGX:AP4's ROC (Joel Greenblatt) % is ranked better than 78.61% of 837
companies
in the Medical Devices & Instruments industry
Industry Median: 4.6
vs SGX:AP4: 28.65
Riverstone Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -30.30% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Riverstone Holdings ROC (Joel Greenblatt) % Related Terms
Riverstone Holdings ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Riverstone Holdings's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:AP4 vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Riverstone Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riverstone Holdings ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Riverstone Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Riverstone Holdings's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 29.43% mean?
Riverstone Holdings (SGX:AP4) has a ROC (Joel Greenblatt) % of 29.43% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Riverstone Holdings and its competitors. This is near median its historical median of 32.47. Over the past decade, Riverstone Holdings' ROC (Joel Greenblatt) % has ranged from 24.19 to 231.10. According to the industry distribution chart, Riverstone Holdings ranks #179 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 21.4%.
Is Riverstone Holdings' ROC (Joel Greenblatt) % too high?
Riverstone Holdings' current ROC (Joel Greenblatt) % of 29.43% is near median its 10-year median of 32.47. Over the past 10 years, this metric has ranged from a low of 24.19 to a high of 231.10. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.60. Riverstone Holdings' value of 29.43% is 539.8% above this industry median. Based on the distribution chart, Riverstone Holdings ranks #179 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Riverstone Holdings has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Riverstone Holdings ranks #179 out of 837 companies for ROC (Joel Greenblatt) %. This places Riverstone Holdings in the top 21% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.60. Riverstone Holdings' value of 29.43% is 539.8% above this benchmark. Historically, Riverstone Holdings' own ROC (Joel Greenblatt) % has ranged from 24.19 to 231.10 over the past decade. While the company's 10-year median is 32.47 vs. the industry median of 4.60, Riverstone Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.60, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riverstone Holdings's current ROC (Joel Greenblatt) % of 29.43% is 539.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Riverstone Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riverstone Holdings's current ROC (Joel Greenblatt) % is 29.43%, which is near median its own 10-year median of 32.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.87, compared to a current price of S$0.87 — trading 0.6% below its estimated fair value. The current ROC (Joel Greenblatt) % is 29.43%, which is near median its 10-year median of 32.47 and 539.8% above the Medical Devices & Instruments industry median of 4.60. Riverstone Holdings' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current ROC (Joel Greenblatt) % is 29.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?
Based on GuruFocus' analysis, Riverstone Holdings stock appears to be undervalued.
The current stock price of S$0.87 is trading 0.6% below its estimated GF Value™ of S$0.87.
GuruFocus considers Riverstone Holdings to be Fairly Valued.
Key valuation signals for SGX:AP4:
ROC (Joel Greenblatt) %: 29.43% (near median its 10-year median of 32.47)
GF Value™: S$0.87 vs. price of S$0.87 (0.6% below fair value)
Industry Position: 539.8% above the Medical Devices & Instruments median (#179 of 837)
No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
65GF Score
Get the complete analysis for SGX:AP4
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:AP4 has been successfully added to your 
